Saad Mark E bought AXSM
September 5, 2025 · Form 4 insider transaction
Saad Mark E bought 9,127 shares of Axsome Therapeutics, Inc. at $9.00 per share, a transaction worth $82.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,127
Price
$9.00
Total value
$82.1K
InsiderSaad Mark E
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 5, 2025
Filing dateSeptember 5, 2025
Shares owned after19,129
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an exercise of stock options prior to the 10-year expiration date of such options, which would occur within the next two months.; Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed.